{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:39:17Z","timestamp":1792640357096,"version":"4.5.0"},"reference-count":27,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2004,2,18]],"date-time":"2004-02-18T00:00:00Z","timestamp":1077062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Neurology"],"published-print":{"date-parts":[[2004,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pompe's disease is an autosomal recessive myopathy. The characteristic lysosomal storage of glycogen is caused by acid \u03b1\u2010glucosidase deficiency. Patients with late\u2010onset Pompe's disease present with progressive muscle weakness also affecting pulmonary function. In search of a treatment, we investigated the feasibility of enzyme replacement therapy with recombinant human \u03b1\u2010glucosidase from rabbit milk. Three patients (aged 11, 16, and 32 years) were enrolled in the study. They were all wheelchair\u2010bound and two of them were ventilator dependent with a history of deteriorating pulmonary function. After 3 years of treatment with weekly infusions of \u03b1\u2010glucosidase, the patients had stabilized pulmonary function and reported less fatigue. The youngest and least affected patient showed an impressive improvement of skeletal muscle strength and function. After 72 weeks of treatment, he could walk without support and finally abandoned his wheelchair. Our findings demonstrate that recombinant human \u03b1\u2010glucosidase from rabbit milk has a therapeutic effect in late\u2010onset Pompe's disease. There is good reason to continue the development of enzyme replacement therapy for Pompe's disease and to explore further the production of human therapeutic proteins in the milk of mammals. Ann Neurol 2004;55:000\u2013000<\/jats:p>","DOI":"10.1002\/ana.20019","type":"journal-article","created":{"date-parts":[[2004,3,24]],"date-time":"2004-03-24T08:01:25Z","timestamp":1080115285000},"page":"495-502","source":"Crossref","is-referenced-by-count":188,"title":["Enzyme replacement therapy in late\u2010onset Pompe's disease: A three\u2010year follow\u2010up"],"prefix":"10.1002","volume":"55","author":[{"given":"L\u00e9on P. F.","family":"Winkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M. P.","family":"Van den Hout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep H. J.","family":"Kamphoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janus A. M.","family":"Disseldorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Remmerswaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem F. M.","family":"Arts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Christa B.","family":"Loonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold G.","family":"Vulto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A.","family":"Van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"De Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Hop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Peter A.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart K.","family":"Shapira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke A.","family":"Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold J. J.","family":"Reuser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ans T.","family":"Van der Ploeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto P.","family":"van Diggelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,3,21]]},"reference":[{"key":"e_1_2_6_2_2","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3389","author":"Hirschhorn R","year":"2000"},{"key":"e_1_2_6_3_2","series-title":"Myology","first-page":"1533","author":"Engel A","year":"1994"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.112.2.332"},{"key":"e_1_2_6_5_2","first-page":"1045","article-title":"From cytosis to lysosomes","volume":"23","author":"De Duve C","year":"1964","journal-title":"Fed Proc Am Soc Exp Biol"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02533-2"},{"key":"e_1_2_6_7_2","article-title":"Long\u2010term intravenous treatment of Pompe's disease with recombinant human alpha\u2010glucosidase from milk","author":"Van den Hout JMP","journal-title":"Pediatrics"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105233242104"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2743"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450102"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101183440304"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00314479"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2720493"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/7.11.1815"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/8.12.2145"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010383421286"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00125817-200103000-00008"},{"key":"e_1_2_6_18_2","first-page":"132","article-title":"Biochemical, immunological, and cell genetic studies in glycogenosis type II","volume":"30","author":"Reuser AJ","year":"1978","journal-title":"Am J Hum Genet"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10381"},{"key":"e_1_2_6_20_2","unstructured":"Van der PloegRJO.Hand\u2010held dynamometry. Thesis. Groningen: Rijksuniversiteit Groningen Department of Neurology 1992."},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-8966(01)00193-6"},{"key":"e_1_2_6_22_2","volume-title":"Aids to the investigation of the peripheral nervous system","author":"Tindall B","year":"1986"},{"key":"e_1_2_6_23_2","volume-title":"Gross motor function measure manual","author":"Russel D","year":"1993"},{"key":"e_1_2_6_24_2","volume-title":"Pediatric evaluation of disability inventory","author":"Haley SM","year":"1992"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.2001.91.2.534"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-002-1015-8"},{"key":"e_1_2_6_27_2","first-page":"92","article-title":"Transgenic technology in the production of therapeutic proteins","author":"Dimond PF","year":"2000","journal-title":"Innovations Pharmaceutical Technol"},{"key":"e_1_2_6_28_2","first-page":"5","article-title":"Brave new world of pharmaceuticals","volume":"365","year":"2002","journal-title":"Economist"}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fana.20019","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.20019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T14:30:14Z","timestamp":1695911414000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.20019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,21]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["10.1002\/ana.20019"],"URL":"https:\/\/doi.org\/10.1002\/ana.20019","archive":["Portico"],"relation":{},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,21]]}}}